JQ-1 carboxylic acid free base
JQ-1 carboxylic acid, a-JQ-1 derivative, is a potent BET bromodomain inhibitor.
For research use only. Not for human or veterinary use.
Target
Epigenetic Reader Domain
PD-1/PD-L1
Ligands for Target Protein for PROTAC
Androgen Receptor
Ligands for E3 Ligase
Research area
Cancer
Purity >98%
Stock Inquire
JQ-1 carboxylic acid structure
CAS No.: 202592-23-2
Pack sizes & pricing
Description
JQ-1 carboxylic acid, a (+)-JQ-1 derivative, is a potent BET bromodomain inhibitor. JQ-1 carboxylic acid can be used to synthesize PROTAC, which can target the degradation of BRD4.
Biological activity
JQ-1 carboxylic acid, a type of (+)-JQ-1 derivative, is a potent BET bromodomain inhibitor for downregulating PD-L1 expression on the surface of tumor cells. JQ-1 carboxylic acid can be used as a precursor to synthesize PROTACs, which targets BET bromodomains.
Identifiers
- SMILES
-
CC1=NN=C2[C@H](CC(O)=O)N=C(C3=C(SC(C)=C3C)N12)C1=CC=C(Cl)C=C1 - InChIKey
-
LJOSBOOJFIRCSO-AWEZNQCLSA-N
Specifications
- MW (average)
- 400.8820
- Formula
- C19H17ClN4O2S
- CAS No.
- 202592-23-2
- Physical state
- Solid
- Color
- White to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20°C 3 years; 4°C 2 years. In solvent -20°C 1 year
Solubility
Soluble in DMSO
Documents
References
[1]. Huang Y, et, al. Design, Synthesis, and Evaluation of Trivalent PROTACs Having a Functionalization Site with Controlled Orientation. Bioconjug Chem. 2022 Jan 19;33(1):142-151.
[2]. Chen W, et, al. Dual drugs decorated bacteria irradiate deep hypoxic tumor and arouse strong immune responses. Biomaterials. 2022 Jul;286:121582.
Same target
Search Epigenetic Reader Domain- BP-00006 SLF Exclusive free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00063 PT-179 free base · >98%
- BP-00104 BMS-986397 free base · >98%
- BP-00726 Ortho-AP1867 free base · >98%
- BP-00867 BN-104 free base · >98%
- BP-01096 PROTAC AR Degrader-5 free base · >98%
- BP-01267 MDM2-IN-1 free base · >98%
Same research area
Search Cancer- BP-00008 NSC-339004 free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%
- BP-00044 Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP free base · >98%
- BP-00084 ORIC-944 free base · >98%